Biotech

All Articles

Lundbeck slashes value of $250M Abide purchase after ache problem

.Lundbeck is slashing the book market value of its $250 million Abide Rehabs buyout in feedback to p...

Real- Globe Information Fulfills Professional Trial Design: Enhancing Methods and Site Collection

.The assimilation of real-world records (RWD) right into protocol usefulness as well as internet sit...

Where are they now? Overtaking previous Intense 15 guest of honors

.At this year's Fierce Biotech Top in Boston ma, our company caught up with leaders in the biotech m...

Merck snaps up preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is actually taking down $30 thousand ahead of time to acquire Yale spinout Modifi Bi...

Radiopharma Alpha-9 increases $175M collection C to cash scientific push

.Alpha-9 Oncology has raised a $175 million collection C cycle to bankroll its clinical-stage radiop...

Ocuphire to completely transform right into genetics therapy biotech via Opus buyout

.Eye medicine maker Ocuphire Pharma is actually acquiring genetics therapy creator Piece Genetic mak...

Roche culls cough applicant, turns KRAS course in Q3 improve

.Roche's severe cough plan has faltered to a halt. The drugmaker, which axed the plan after the medi...

Merck- Gilead long-acting dental combination subdues HIV for 48 weeks

.Gilead Sciences and Merck &amp Co. have led their once-weekly HIV combination treatment past an add...

Lykos allows FDA look at that MDMA approval depends on fresh trial

.Lykos Rehabs may have lost three-quarters of its own team following the FDA's being rejected of its...

Septerna organizes $158M IPO to finance readouts for GPCR pipeline

.Septerna might be as yet to reveal "any type of relevant medical data," but the biotech precisely p...